PIK3CA Antikörper (Catalytic Subunit alpha)
Kurzübersicht für PIK3CA Antikörper (Catalytic Subunit alpha) (ABIN7602952)
Target
Alle PIK3CA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- Catalytic Subunit alpha
-
Verwendungszweck
- Anti-PI 3 kinase p110 alpha Monoclonal Antibody
-
Produktmerkmale
- Anti-PI 3 kinase p110 alpha Monoclonal Antibody (ABIN7602952). Tested in WB, ICC/IF, IP applications. This antibody reacts with Human, Mouse, Rat.
-
Aufreinigung
- Affinity-chromatography
-
Immunogen
- A synthesized peptide derived from human PI 3 Kinase catalytic subunit alpha
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:1000-1:2000
ICC/IF 1:50-1:200
IP 1:20 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL
-
Konzentration
- Lot specific
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.
-
-
- PIK3CA (Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide (PIK3CA))
-
Andere Bezeichnung
- PIK3CA
-
Hintergrund
-
Synonyms: Signal transducer and activator of transcription 3,Acute-phase response factor,STAT3,APRF,
Tissue Specificity: Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
-
Molekulargewicht
- 131 kDa
-
UniProt
- P42336
-
Pathways
- PI3K-Akt Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, AMPK Signaling, Interferon-gamma Pathway, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Inositol Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, VEGF Signaling
Target
-